Kidney Stone Management Devices Market

Kidney Stone Management Devices Market Outlook (2023 to 2033)

The global kidney stone management devices market is valued at US$ 1.9 billion in 2023 and is forecasted to reach a revenue of US$ 3.1 billion by the end of 2033, with global demand for kidney stone management devices increasing at 5% CAGR over the next ten years.

Kidney stones are hard deposits of minerals caused by a high concentration of elements such as phosphate, uric acid, calcium, etc. Kidney stones can cause severe discomfort and pain while passing through the urinary tract; they don’t cause any permanent damage except in rare cases.

• The most common type of kidney stones affecting people around the world are calcium stones.

Staying hydrated is the key to expelling and treating issues caused by kidney stones among individuals. Changing global climate and rising global warming effect is heating the planet in ways we cannot imagine and this is also a factor that is anticipated to increase the risk of kidney stones among people around the world.

• As per statistics listed on the National Kidney Foundation website, one in ten people is estimated to have kidney stones in their lifetime.

Kidney stone management devices help relieve pain and assist in the treatment of kidney stones by breaking them through oral medications and hydration or other surgical procedures. The rising prevalence of kidney disorders, changing dietary preferences, adoption of sedentary lifestyles, and technological advancements in kidney stone retrieval devices are other prospects that could bolster kidney stone management device sales through 2033.

• King George Hospital, a part of Barking, Havering and Redbridge University Hospital Trust recently installed a new ESWL (Extracorporeal shockwave lithotripsy) machine that increased the capacity of the Urology department to serve up to 50 patients per week.

The prospect of using precision medicine for kidney stone treatment is also being explored by several research centers and medical technology companies, which could transform the future of kidney stone management devices over the coming years.

• Researchers at the University of California, San Francisco, have developed a new kidney injury test (KIT), which is a point-of-care urine spot analysis assay that measures levels of 4 biomarkers and offers a ‘KIT score’. This score is capable of diagnosing calcium-based stones in patients.

On the flip side, lack of awareness about kidney stone symptoms and improper diagnosis of the condition are prime restraints that are anticipated to obstruct market development throughout the forecast period.

Sales of kidney stone management devices in North America are anticipated to account for a commanding share of 40% of the global market over the next ten years.

Report Attributes	Details
Kidney Stone Management Devices Market Size (2023)	US$ 1.9 Billion
Projected Market Value (2033F)	US$ 3.1 Billion
Global Market Growth Rate (2023 to 2033)	5% CAGR
Growth Rate of Ureteroscopes (2023 to 2033)	5.5% CAGR
Market Share of North America (2022)	~40%
Canada Market Growth Rate (2023 to 2033)	4% CAGR
Market Share of Lithotripsy Devices (2023)	~30%
Key Companies Profiled	Siemens Healthineers AG Inceler Medikal Co. Ltd. DirexGroup EDAP TMS S.A. Dornier MedTech (Subsidiary of Accuron MedTech) Lumenis Ltd. GEMSS Co. Ltd. Richard Wolf GmbH. STORZ MEDICAL AG

How Can New Companies Make a Mark in This Industry?

“Start-ups Focusing on Minimally Invasive and Non-invasive Kidney Stone Removal Procedures”

Kidney stone removal has been a crucial aspect of kidney stone management that has the potential to solve the issue or complicate it further. Several new and established kidney stone management device companies are investing in the research and development of novel solutions and procedures to remove kidney stones effectively without risking complications.

Incoming kidney stone management device manufacturers are focusing on raising new capital to fund their research and hasten the launch of novel minimally invasive and non-invasive stone removal procedures and products.

• In November 2022, a United States-based medical technology start-up called Sonomotion, announced that it had raised US$ 12.4 billion in a Series C funding round that was co-led by Lyndon Rive and Advanced MedTech Holdings. The company had plans to use this capital to advance the development of its ultrasound solutions to dislodge, expel, and fragment kidney stones.
• In July 2022, Calyxo, an innovation-driven medical start-up, raised US$ 32.7 billion in a Series C financing round led by CRG and Questa Capital. The company has developed a device to retrieve and remove residual kidney stone fragments immediately after laser lithotripsy procedures to avoid complications and further health risks.

This latest kidney stone management products market research report by Fact.MR, a market research and competitive intelligence provider, proffers an exhaustive analysis of trends such as supply chain management, local supply, safety regulations, product standards, etc., to provide a realistic current and forecasted assessment of the global marketplace.

Country-wise Insights

How are Kidney Stone Management Device Sales Evolving in Japan?

“Rising Prevalence of Kidney Stones among Japanese People Creating Moneymaking Opportunities”

The incidence of kidney stone disorders has been increasing in Japan in recent years and this trend is projected to influentially drive demand for kidney stone management devices in the country going forward. Kidney stones are among one of the most common urological disorders in the country at present.

Growing adoption of advanced kidney stone removal procedures and increasing availability of minimally invasive and non-invasive kidney procedures are also anticipated to bolster market growth in the country through 2033.

What Attracts Kidney Stone Management Device Companies to Europe?

“Increasing Healthcare Expenditure and Growing Popularity of Non-invasive Procedures”

Healthcare expenditure in European countries has increased substantially in recent years and this is projected to be a key factor governing kidney stone management product sales in the region through 2033. Supportive government initiatives to bolster healthcare services, rising investments in medical research and development, and increasing awareness regarding kidney disorders are other prospects that could benefit market growth over the coming years.

Increasing product approvals and the launch of novel kidney stone removal procedures and products in countries such as Germany, France, Italy, and the United Kingdom are also slated to favor kidney stone management device demand in the future.

• Shipments of kidney stone management devices in Germany are expected to progress at 3% CAGR from 2023 to 2033.

In contrast, lack of awareness about kidney stones and the scarcity of skilled medical professionals are expected to hamper market evolution in European countries.

Will the United States Be an Opportune Market for Kidney Stone Management Device Vendors?

“Rapid Adoption of Advanced Medical Technologies Offering Immense Business Scope”

The United States is projected to be a highly lucrative market for kidney stone management device companies owing to the presence of developed healthcare infrastructure and favorable medical reimbursement policies. Early adoption of advanced minimally invasive and non-invasive kidney stone removal procedures is also a key factor that is anticipated to sculpt kidney stone management device demand in the country across the forecast period.

• In February 2023, Ethicon, a Johnson & Johnson MedTech company, published a news release and announced that the first patient to receive kidney stone removal with robotic assistance using Ethicon’s MONARCH platform was treated in a clinical study. The adoption of this robotic-assisted surgery could reduce the risk of complications and the need for retreatment after kidney stone removal procedures.

Poor lifestyle choices and increasing consumption of junk food and unhealthy food are also anticipated to play a role in market development in the United States.

Category-wise Insights

Demand for Which Product is Anticipated to Soar in Future?

“Authoritative Market Share to Be Held by Lithotripsy Devices”

Based on product type, the kidney stone management devices market is segmented into lithotripsy devices, ureteroscopes, and nephroscopes.

The low cost of lithotripsy procedures is a prime factor that is projected to bolster the demand for lithotripsy devices over the next ten years. The rising use of lithotripsy devices in the effective treatment of kidney stone issues and the introduction of new-generation lithotripters with advanced capabilities are also anticipated to contribute to the increasing sales of lithotripsy devices.

• At present, lithotripsy devices account for nearly 30% of the global market share.
• Demand for ureteroscopes is anticipated to increase at a steady CAGR of 5.5% over the next ten years.

Competitive Landscape

Top kidney stone management device suppliers are penning agreements for collaborations, partnerships, and acquisitions that help them expand their business scope and increase their share in the global competitive landscape.

• In June 2022, Endoluxe, a biotechnology company, entered into a multi-year exclusive distribution agreement with Dornier MedTech, particularly for the urology market and to strengthen its urology devices portfolio.
• In September 2021, Boston Scientific, a multinational manufacturer of medical devices, announced that it has concluded the acquisition of Lumenis’s surgical business at an upfront payment of US$ 1.07 billion. Through this acquisition, Boston strengthened its urology product portfolio as it added the MOSES technology from Lumenis used for kidney stone management.

Kidney Stone Management Devices Industry Research Segmentation

• By Product Type :

  • Lithotripsy Devices
  • Ureteroscopes
  • Nephroscopes

• By End User :

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

• By Region :

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA